CAUSES OF DEATH IN RODENT TOXICITY AND CARCINOGENICITY STUDIES

被引:26
作者
ETTLIN, RA
STIRNIMANN, P
PRENTICE, DE
机构
[1] Sandoz Pharma Ltd
[2] Prentice Consultancy Services Ltd, GB-Godmanchester
关键词
LIVER TUMORS; LUNG TUMORS; TUMORS OF THE HEMOLYMPHORETICULAR SYSTEM; MAMMARY GLAND TUMORS; PITUITARY TUMORS; SKIN TUMORS; SKIN ULCERATIONS; CHRONIC PROGRESSIVE NEPHROPATHY; POLYARTERITIS;
D O I
10.1177/019262339402200210
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Peto test procedures for the statistical evaluation of carcinogenicity studies require that each tumor in an animal that died intercurrently (or was sacrificed in extremis) be classified as either fatal, probably fatal, incidental, or probably incidental. There is considerable controversy as to whether or not the cause of death can be established with accuracy in rodent studies. In the present article, the causes of death or ill-being as found in 10 consecutive carcinogenicity studies - 5 studies with 2400 OFA (Sprague-Dawley-derived) and Wistar rats and 5 studies with 2400 OF1 and NMRI mice-were re-examined. A cause of death or moribund state had been established in more than 80% of the cases in rats and in more than 70% in mice. These causes were, in rats, mainly pituitary tumors, chronic progressive nephropathy (males), mammary gland tumors (females), and subcutaneous tumors (males); in mice, mainly hemolymphoreticular tumors, lung tumors, liver tumors (males), and glomerulonephropathy. The criteria used for determining the tumorous or non-tumorous lesions as the cause of death were based on in-life and pathological findings. The validity of such procedures, the possibility of improving criteria in the future, and the usefulness of establishing causes of death in safety assessment are discussed.
引用
收藏
页码:165 / 178
页数:14
相关论文
共 25 条
[1]  
Baumgart J., Zhukovskaya N.V., Anisimov V.N., Carcinogenesis and aging, Exp. Pathol, 33, pp. 239-248, (1988)
[2]  
Bomhard E., Karbe E., Loeser E., Spontaneous tumors of 2000 Wistar TNO/W.70 rats in two-year carcinogenicity studies, JEPTO, 7, pp. 35-52, (1986)
[3]  
Burek J.D., Pathology of Aging Rats, (1978)
[4]  
Dinse G.E., Simple parametric analysis of animal tumorigenicity data, J. Am. Statist. Assoc, 83, pp. 638-649, (1988)
[5]  
Dinse G.E., Haseman J.K., Logistic regression analysis of incidental-tumor data from animal carcinogenicity experiments, Fund. Appl. Toxicol, 6, pp. 44-52, (1986)
[6]  
Ettlin R.A., Oberholzer M., Perentes E., Ryfiel B., Kolopp M., Qureshi S., A brief review of modern toxicologic pathology in regulatory and explanatory toxicity studies of chemicals, Arch. Toxicol, 65, pp. 445-453, (1991)
[7]  
Ettlin R.A., Perentes E., Kolopp M., Lardelli P., Arnold J., Karamitopoulou E., Oberholzer M., Overview of quantitative methods in toxicologic pathology, In Vivo, 7, pp. 315-324, (1993)
[8]  
Faccini J.M., Abbott D.P., Paulus G.J.J., Mouse Histopathology, a Glossary for Use in Toxicity and Carcinogenicity Studies, (1990)
[9]  
Glaister J.R., Principles of Toxicologic Pathology, pp. 160-203, (1986)
[10]  
Gold L.S., Ward J.M., Bernstein L., Stern B., Association between carcinogenic potency and tumor pathology in rodent carcinogenesis bioassays, Fund. Appl. Toxicol, 6, pp. 677-690, (1986)